BACKGROUND: Diethylnitrosamine is a well known carcinogen that induces cancers of various organs in mice and rats. Using FVB/N mouse strain, here we show that diethylnitrosamine induces primarily lung adenocarcinomas with modest tumor development in the liver, offering a new model to study chemical carcinogenesis in the lung. METHODS: Animals were exposed to a single high dose of diethylnitrosamine, and more than 70% of the mice developed lung cancer. To obtain a new transplantable tumor line, pieces of primary tumors were inoculated and maintained subcutaneously in the same mouse strain. We used immunohistochemistry to characterize the tumor for main lung adenocarcinoma markers. We searched for mutations in KRAS exon 2 and EGFR exon 19, 2...
Lung cancer is a devastating disease with very poor prognosis. The design of better treatments for p...
Nuclear receptor subfamily 1, group I, member 3 (NR1I3) is reported to be a possible novel therapeut...
Uncovering novel growth modulators for non-small cell lung cancer (NSCLC) may lead to new therapies ...
Abstract Background Diethylnitrosamine is a well known carcinogen that induces cancers of various or...
Background: Improved understanding of lung cancer development and progression, including insights fr...
Lung cancer is the leading cause of cancer death in the United States and the most commonly diagnose...
BACKGROUND: Nonsmall cell lung carcinomas (NSCLCs) are associated with very dismal prognoses, and ad...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biology, 2003.Includes bibliographi...
: Aims: Lung cancer is the leading cause of cancer death worldwide, and tobacco smoking is a recogni...
Development of novel methods of early diagnosis of lung cancer is one of the major tasks of contempo...
The role of O6-methylguanine (O6MG) DNA adduct formation and persistence in the formation of 4-(meth...
Background: Non-small cell lung cancer (NSCLC) accounts for 81% of all cases of lung cancer and they...
PURPOSE: As previously described, SPC/myc transgenic mice developed bronchioloalveolar adenocarcinom...
Despite the high prevalence and poor outcome of patients with metastatic lung cancer the mechanisms...
Abstract Mice have served as an excellent model to understand the etiology of lung cancer for years....
Lung cancer is a devastating disease with very poor prognosis. The design of better treatments for p...
Nuclear receptor subfamily 1, group I, member 3 (NR1I3) is reported to be a possible novel therapeut...
Uncovering novel growth modulators for non-small cell lung cancer (NSCLC) may lead to new therapies ...
Abstract Background Diethylnitrosamine is a well known carcinogen that induces cancers of various or...
Background: Improved understanding of lung cancer development and progression, including insights fr...
Lung cancer is the leading cause of cancer death in the United States and the most commonly diagnose...
BACKGROUND: Nonsmall cell lung carcinomas (NSCLCs) are associated with very dismal prognoses, and ad...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biology, 2003.Includes bibliographi...
: Aims: Lung cancer is the leading cause of cancer death worldwide, and tobacco smoking is a recogni...
Development of novel methods of early diagnosis of lung cancer is one of the major tasks of contempo...
The role of O6-methylguanine (O6MG) DNA adduct formation and persistence in the formation of 4-(meth...
Background: Non-small cell lung cancer (NSCLC) accounts for 81% of all cases of lung cancer and they...
PURPOSE: As previously described, SPC/myc transgenic mice developed bronchioloalveolar adenocarcinom...
Despite the high prevalence and poor outcome of patients with metastatic lung cancer the mechanisms...
Abstract Mice have served as an excellent model to understand the etiology of lung cancer for years....
Lung cancer is a devastating disease with very poor prognosis. The design of better treatments for p...
Nuclear receptor subfamily 1, group I, member 3 (NR1I3) is reported to be a possible novel therapeut...
Uncovering novel growth modulators for non-small cell lung cancer (NSCLC) may lead to new therapies ...